Generic medicine
Bicalutamide
Bicalutamide · Oncology & immunology · Antineoplastic medicines
Data statusRegistration & price fields require source verification.
11brands/products
8companies
11with current prices
Available dosage forms
Tap a form to filter the brand listChoose a form
Pakistan brand index
Available brands
Print / Save PDFAll 11 brands
11 results
| Brand | Manufacturer | Strength | Form | Pack | Reg. no. | Official price | Unit price |
|---|---|---|---|---|---|---|---|
| Bicalutacal | Caliph Pharmaceuticals (Pvt) Ltd. | 150 mg | Tablet | 1's | 100256 | PKR 453.992026-06-24 | PKR 453.99/ tablet |
| Bicalutacal | Caliph Pharmaceuticals (Pvt) Ltd. | 150 mg | Tablet | 28's | 100256 | PKR 12,711.772026-06-24 | PKR 453.99/ tablet |
| Bicalutacal | Caliph Pharmaceuticals (Pvt) Ltd. | 50 mg | Tablet | 28's | 100255 | PKR 5,444.382026-06-24 | PKR 194.44/ tablet |
| BICAMIDE/BICALUMIDE | Umar Pharma Pvt Ltd | 50 mg | Tablet | 28,S | 085044 | PKR 5,378.272026-07-27 | PKR 192.08/ tablet |
| Bicluta | Helix Pharma (Pvt)., Ltd. | 50 mg | Tablet | 28's | 116038 | PKR 6,390.052026-07-27 | PKR 228.22/ tablet |
| Bitamid | Pharmasol (Pvt) Ltd. | 50 mg | Tablet | 28's | 091811 | PKR 5,919.522026-07-24 | PKR 211.41/ tablet |
| Bitamid | Pharmasol (Pvt) Ltd. | 50 mg | Tablet | 10's | 091811 | PKR 2,145.312026-07-24 | PKR 214.53/ tablet |
| CALUTIDE | AJ Mirza Pharma Pvt Ltd | 50 mg | Tablet | 10's | 045650 | PKR 2,729.552025-08-19 | PKR 272.96/ tablet |
| Casodex | AstraZeneca Pharmaceuticals Pakistan Private Limited | 50 mg | Tablet | 28's | 027380 | PKR 23,223.822025-08-01 | PKR 829.42/ tablet |
| Casomid 50mg Film Coated | Himmel Pharmaceuticals Private Limited | 50 mg | Tablet | 28's | 097366 | PKR 6,390.052026-07-29 | PKR 228.22/ tablet |
| Cosalon 50 | Hakimsons (Impex) (Pvt.) Ltd. | 50 mg | Tablet | 10'S | 074857 | PKR 2,250.032026-07-23 | PKR 225.00/ tablet |
Independent editorial layer
Medicine information
Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.